Australia Approves First FCS Treatment REDEMPLO by Arrowhead
Arrowhead Pharmaceuticals, Inc. has announced that Australia’s Therapeutic Goods Administration (TGA) has approved REDEMPLO® (plozasiran), marking the first authorized treatment in the…
Read More...
Read More...
